Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Materialise NV stock logo
MTLS
Materialise
$5.11
-1.7%
$5.32
$3.93
$9.69
N/A1.24123,028 shs122,916 shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$15.05
+4.8%
$14.18
$12.39
$37.67
$289.02M0.85377,623 shs590,032 shs
TruBridge, Inc. stock logo
TBRG
TruBridge
$20.09
-2.7%
$20.89
$11.39
$32.00
$309.84M0.5583,040 shs91,035 shs
Zenvia Inc. stock logo
ZENV
Zenvia
$1.26
-5.6%
$1.53
$1.02
$3.03
$69.07M1.7973,855 shs159,926 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Materialise NV stock logo
MTLS
Materialise
+2.56%+4.63%+1.76%-4.59%+2.97%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
+3.38%+1.70%+1.27%-24.70%-56.23%
TruBridge, Inc. stock logo
TBRG
TruBridge
+3.72%+2.28%+5.41%-10.53%+69.88%
Zenvia Inc. stock logo
ZENV
Zenvia
-25.49%-14.74%-15.82%-8.28%-8.28%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Materialise NV stock logo
MTLS
Materialise
$5.11
-1.7%
$5.32
$3.93
$9.69
N/A1.24123,028 shs122,916 shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$15.05
+4.8%
$14.18
$12.39
$37.67
$289.02M0.85377,623 shs590,032 shs
TruBridge, Inc. stock logo
TBRG
TruBridge
$20.09
-2.7%
$20.89
$11.39
$32.00
$309.84M0.5583,040 shs91,035 shs
Zenvia Inc. stock logo
ZENV
Zenvia
$1.26
-5.6%
$1.53
$1.02
$3.03
$69.07M1.7973,855 shs159,926 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Materialise NV stock logo
MTLS
Materialise
+2.56%+4.63%+1.76%-4.59%+2.97%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
+3.38%+1.70%+1.27%-24.70%-56.23%
TruBridge, Inc. stock logo
TBRG
TruBridge
+3.72%+2.28%+5.41%-10.53%+69.88%
Zenvia Inc. stock logo
ZENV
Zenvia
-25.49%-14.74%-15.82%-8.28%-8.28%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Materialise NV stock logo
MTLS
Materialise
0.00
N/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
2.57
Moderate Buy$26.5076.08% Upside
TruBridge, Inc. stock logo
TBRG
TruBridge
2.50
Moderate Buy$21.255.77% Upside
Zenvia Inc. stock logo
ZENV
Zenvia
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ZENV, MTLS, TBRG, and SLP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
7/15/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweightSector Weight
7/15/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
7/15/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$28.00 ➝ $20.00
7/14/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweightSector Weight$40.00 ➝ $25.00
7/7/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$41.00 ➝ $25.00
6/18/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
JMP Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Perform
6/13/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$45.00 ➝ $36.00
(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Materialise NV stock logo
MTLS
Materialise
$288.70MN/A$0.52 per share9.85$4.55 per shareN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$70.01M4.33$0.80 per share18.72$9.12 per share1.65
TruBridge, Inc. stock logo
TBRG
TruBridge
$339.17M0.89$1.87 per share10.77$11.30 per share1.78
Zenvia Inc. stock logo
ZENV
Zenvia
$177.97M0.37N/AN/A$2.75 per share0.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Materialise NV stock logo
MTLS
Materialise
$14.54M$0.1051.11N/A2.08%2.25%1.41%10/23/2025 (Estimated)
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$9.95M-$3.15N/A11.94N/A-78.63%11.62%10.84%10/22/2025 (Estimated)
TruBridge, Inc. stock logo
TBRG
TruBridge
-$19.67M-$0.84N/A14.45N/A-3.63%3.30%1.43%11/6/2025 (Estimated)
Zenvia Inc. stock logo
ZENV
Zenvia
-$28.67M-$0.32N/A62.75N/A-10.62%-14.01%-6.40%11/17/2025 (Estimated)

Latest ZENV, MTLS, TBRG, and SLP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/10/2025Q2 2025
Zenvia Inc. stock logo
ZENV
Zenvia
-$0.1262-$0.14-$0.0138-$0.14$213.34 million$50.43 million
7/14/2025Q3 2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.26$0.45+$0.19-$3.35$22.83 million$20.36 million
7/2/2025Q1 2025
Zenvia Inc. stock logo
ZENV
Zenvia
-$0.1262$0.01+$0.1362$0.01$213.34 million$50.47 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Materialise NV stock logo
MTLS
Materialise
N/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/AN/AN/AN/AN/A
TruBridge, Inc. stock logo
TBRG
TruBridge
N/AN/AN/AN/AN/A
Zenvia Inc. stock logo
ZENV
Zenvia
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Materialise NV stock logo
MTLS
Materialise
0.15
2.16
2.00
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/A
5.11
5.11
TruBridge, Inc. stock logo
TBRG
TruBridge
0.94
1.80
1.79
Zenvia Inc. stock logo
ZENV
Zenvia
0.04
0.44
0.44

Institutional Ownership

CompanyInstitutional Ownership
Materialise NV stock logo
MTLS
Materialise
19.30%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
78.08%
TruBridge, Inc. stock logo
TBRG
TruBridge
88.64%
Zenvia Inc. stock logo
ZENV
Zenvia
49.25%

Insider Ownership

CompanyInsider Ownership
Materialise NV stock logo
MTLS
Materialise
1.23%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
19.40%
TruBridge, Inc. stock logo
TBRG
TruBridge
10.70%
Zenvia Inc. stock logo
ZENV
Zenvia
78.37%
CompanyEmployeesShares OutstandingFree FloatOptionable
Materialise NV stock logo
MTLS
Materialise
2,514N/AN/AOptionable
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
16020.13 million16.22 millionOptionable
TruBridge, Inc. stock logo
TBRG
TruBridge
3,20015.01 million13.41 millionOptionable
Zenvia Inc. stock logo
ZENV
Zenvia
1,08051.94 million11.23 millionNot Optionable

Recent News About These Companies

Zenvia Inc. (ZENV) Q2 2025 Earnings Call Transcript
Zenvia Inc.: ZENVIA Reports Q2 2025 Results
Zenvia Reports Q2 2025 Growth in Customer Cloud Revenues
Zenvia Inc. Submits SEC Report for September 2025
Zenvia Inc. Reports Financial Losses for Mid-2025
ZENVIA Reports Q2 2025 Results
Zenvia (ZENV) to Release Earnings on Thursday
ZENVIA sets agenda for second quarter 2025 results
ZENVIA Reports Q1 2025 Results - Seeking Alpha
ZENVIA Reports Q1 2025 Results - Morningstar
Zenvia Inc. (ZENV) Q1 2025 Earnings Call Transcript
ZENVIA Reports Q1 2025 Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Materialise stock logo

Materialise NASDAQ:MTLS

$5.11 -0.09 (-1.73%)
Closing price 04:00 PM Eastern
Extended Trading
$5.14 +0.03 (+0.67%)
As of 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Simulations Plus stock logo

Simulations Plus NASDAQ:SLP

$15.05 +0.69 (+4.81%)
Closing price 04:00 PM Eastern
Extended Trading
$14.53 -0.52 (-3.46%)
As of 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

TruBridge stock logo

TruBridge NASDAQ:TBRG

$20.09 -0.55 (-2.66%)
Closing price 04:00 PM Eastern
Extended Trading
$20.12 +0.03 (+0.15%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.

Zenvia stock logo

Zenvia NASDAQ:ZENV

$1.25 -0.08 (-5.64%)
Closing price 03:59 PM Eastern
Extended Trading
$1.28 +0.03 (+2.39%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.